Understanding how specific receptors influence bone formation and growth
Discoidin Domain Receptor 2, β1 Integrins and ECM Control of Bone Formation
This study is looking at how a specific protein called DDR2 helps bones grow and develop, especially by working with collagen, and it's for anyone interested in understanding bone health and finding new ways to treat bone diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11035219 on NIH RePORTER |
What this research studies
This research investigates the role of Discoidin Domain Receptor 2 (DDR2) in bone formation and development, particularly in relation to collagen and its interaction with other receptors. By studying mice with mutations in DDR2, researchers aim to uncover how this receptor affects bone cell differentiation and growth. The project will involve tracking the expression of DDR2 in various bone cells during development and understanding its signaling pathways. This could lead to insights into bone diseases and potential therapeutic targets for improving bone health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic mutations affecting bone growth or development, such as those with spondylo-meta-epiphyseal dysplasia.
Not a fit: Patients with bone disorders unrelated to DDR2 or those without genetic mutations affecting bone formation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for bone disorders and improve bone regeneration strategies.
How similar studies have performed: Previous research has shown promising results in understanding the role of collagen receptors in bone biology, suggesting that this approach could yield valuable insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Franceschi, Renny Theodore — University of Michigan at Ann Arbor
- Study coordinator: Franceschi, Renny Theodore
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.